Companies: 10,795·Total market cap: $144.5T
Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

ELTXNASDAQHealthcare● Active
$13.55
+$0.29(+2.19%)
Market Cap$258616370
P/E Ratio
52W High$14.93
52W Low$7.37
Overview

Elicio Therapeutics, Inc. (ELTX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ELTX · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-2.36eltx eps ttm · eltx earnings per shareEarnings history
PE Ratio (TTM)eltx pe ratio ttm · eltx price to earningsPE Ratio deep dive
Revenue (TTM)0.00eltx revenue ttm · eltx annual revenueFull revenue history
Dividend YieldNo Dividenddoes eltx pay dividends · eltx dividend yieldDividend history
Shares Outstanding15.3Meltx shares outstanding · eltx floatShares outstanding history
Next EarningsAug 6, 2026Est.eltx earnings date · eltx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
elicio therapeutics, inc. revenue · eltx revenue 2025
FY 2025Net Income-$39.6M▲ +23.75% YoY
202320242025
elicio therapeutics, inc. net income · eltx profit 2025
FY 2025EPS$-2.58▲ +39.29% YoY
202320242025
eltx eps · elicio therapeutics, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$40.2MEPS: $-2.36View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy2 analystsis eltx a buy · eltx analyst rating
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$17.00Low
$13.55Current
$17.00Avg Target25.46% upside
$17.00High
eltx price target · eltx 12 month forecast

Total: 2 · Buy rate: 50.0%

The ELTX analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $17.00, representing +25.46% upside from the current price of $13.55.

Stock Performance

Full History
1D+2.19%
1W+18.24%
1M+36.73%
3M+16.51%
YTD+70.23%
1Y+70.01%
5Y+130.05%

About Elicio Therapeutics, Inc.

CEORobert T. Connelly
IPO DateFeb 5, 2021
Employees32
CountryUS
Websiteelicio.com

Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The compan…

what is elicio therapeutics, inc. · eltx stock overview · elicio therapeutics, inc. company profile · who is elicio therapeutics, inc. ceo · eltx NASDAQ · elicio therapeutics, inc. headquarters · elicio therapeutics, inc. business segments

About Stock Overview & Key Data

Elicio Therapeutics, Inc. (ELTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 5, 2021. As of the latest trading session, ELTX stock price is $13.55, with a market capitalization of $258.6M. The stock has returned +70.01% over the past 12 months and +70.23% year-to-date.

According to 2 Wall Street analysts, the consensus rating for Elicio Therapeutics, Inc. stock is Buy, with an average 12-month price target of $17.00. In fiscal year 2025, Elicio Therapeutics, Inc. reported revenue of — and net income of -$39.6M. For detailed data — including Elicio Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Elicio Therapeutics, Inc. (ELTX) stock price is $13.55. The stock is traded on NASDAQ under the ticker symbol ELTX. The 52-week range is $7.37 – $14.93.

ELTX stock priceELTX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice